Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: SB 332235
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

276702-15-9

276702-15-9 structure
276702-15-9 structure
  • Name: SB 332235
  • Chemical Name: SB-332235
  • CAS Number: 276702-15-9
  • Molecular Formula: C13H10Cl3N3O4S
  • Molecular Weight: 410.660
  • Catalog: Signaling Pathways GPCR/G Protein CXCR
  • Create Date: 2018-07-12 23:00:54
  • Modify Date: 2024-01-10 18:59:49
  • SB-332235 is a potent, orally active nonpeptide CXCR2 antagonist, with an IC50 of 7.7 nM. SB-332235 displays 285-fold selectivity for CXCR2 over CXCR1. SB-332235 inhibits acute and chronic models of arthritis in the rabbit. SB-332235 inhibits viability of AML cells[1][2].

Name SB-332235
Synonyms 6-Chloro-3-{[(2,3-dichlorophenyl)carbamoyl]amino}-2-hydroxybenzenesulfonamide
SB-332235
5HLP8UVL8M
Benzenesulfonamide, 6-chloro-3-[[[(2,3-dichlorophenyl)amino]carbonyl]amino]-2-hydroxy-
Description SB-332235 is a potent, orally active nonpeptide CXCR2 antagonist, with an IC50 of 7.7 nM. SB-332235 displays 285-fold selectivity for CXCR2 over CXCR1. SB-332235 inhibits acute and chronic models of arthritis in the rabbit. SB-332235 inhibits viability of AML cells[1][2].
Related Catalog
In Vitro SB-332235 (1-100 μM; 48 hours) inhibits viability of AML cell lines[2]. Cell Viability Assay[2] Cell Line: AML cell Concentration: 1, 10, 100 μM Incubation Time: 48 hours Result: Led to a dose-dependent decrease in proliferation in all cell lines.
In Vivo SB-332235 (25 mg/kg, p.o., b.i.d.) exhibits significantly reduced numbers of total leukocytes in synovial fluids from IL-8-injected knees[1]. SB-332235 (10-25 mg/kg; p.o.; twice a day for 14 days) inhibits chronic Ag-induced arthritis[1]. Animal Model: Adult female New Zealand White rabbits (chronic OVA-induced model of arthritis)[1] Dosage: 10, 25 mg/kg Administration: P.o.; twice a day for 14 days Result: Day-15 synovial fluid leukocyte numbers in OVA-injected knees were significantly reduced in rabbits. The decrease in neutrophils, monocytes, and lymphocytes resulting from treatment with 25 mg/kg of the antagonist was accompanied by a significant reduction in synovial fluid PGE2, LTB4, LTC4, and IL-8 levels.
References

[1]. Podolin PL, et al. A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J Immunol. 2002;169(11):6435-6444.

[2]. Schinke C, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells [published correction appears in Blood. 2015 Jul 16;126(3):425. Barreryo, Laura [corrected to Barreyro, Laura]]. Blood. 2015;125(20):3144-3152.

Density 1.8±0.1 g/cm3
Molecular Formula C13H10Cl3N3O4S
Molecular Weight 410.660
Exact Mass 408.945770
LogP 3.75
Index of Refraction 1.719
Storage condition 2-8°C
Hazard Codes Xi